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Abstract 
Background and purpose: The aim of this pilot study was to determine the feasibility of a 
multicenter, randomized, controlled trial in India of a family-led trained caregiver-delivered 
home-based rehabilitation intervention versus routine care. 
Methods:  A prospective, randomized (within 7 days of hospital admission), blinded 
outcome assessor, controlled trial of structured home-based rehabilitation delivered by 
trained and protocol-guided family caregivers (intervention) versus routine care alone 
(control), in patients with residual disability. Key feasibility measures were recruitment, 
acceptance and adherence to assessment procedures and follow up of participants over 6 
months. 
Results: A total of 104 patients from the stroke unit at Christian Medical College, Ludhiana 
were recruited over 9 months. Recruitment was feasible and accepted by patients and their 
carers. Important observations were made regarding potential unblinding of the participants, 
contamination of therapy between the randomized groups, organization of home visits, and 
resources required for a multicenter study. 
Conclusion: The pilot study established the feasibility of conducting a large scale study of 
family-led, trained caregiver-delivered, home-based stroke rehabilitation in a low resource 
setting. The main phase of the trial ‘ATTEND’ is currently underway in over 10 centers in 
India. 
Clinical trial registration-URL: http://www.clinicaltrials.gov 
Unique identifier: NCTO2123875 
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Introduction 
The Global Burden of Disease project 2010 indicates that most of the global burden of stroke 
is on low and middle income countries (LMICs).1 In India, for example, the annual rate  of 
stroke ranges from 135 to 145 per 100,000,2-4 and a high proportion of survivors are left with 
disability without sufficient access to rehabilitation. 2-4 
While evidence-based treatments for stroke such as acute stroke unit (SU) care5, 6are 
established worldwide, most Indian SUs are located in private hospitals in urban areas. A 
significant proportion of the cost of care is borne by the patients who generally have limited 
access to health insurance.7 The average cost for stroke in a private hospital in India is 
estimated at rupees (INR) 80,612 (USD 1520) for the first 6 months post-stroke, which is 
equivalent to the average per capita income in India, thus making acute care and 
rehabilitation unaffordable to much of the population affected by stroke.8 
Innovative models of stroke care in LMICs may capitalize on the extended family system that 
provides much of the care for the sick or disabled. These attempt to train and empower the 
caregivers as the ‘virtual multidisciplinary team’, to deliver home-based rehabilitation, 
potentially improving outcomes while reducing health care costs. Thus the FAmily-Led 
RehabiliTaTion aftEr stroke in INDia (ATTEND) trial was developed as a modified Early 
Supported Discharge strategy to test the effectiveness of this concept.  
In order to ascertain the feasibility of undertaking such a large-scale investigation across 
multiple sites in India, we undertook a pilot phase to establish the potential for recruitment, 
fidelity of the intervention package and to ensure that the procedures for assessment, 
instruction and follow up were methodologically sound and feasible. 
Methods 
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Design 
A prospective, randomized, open blinded outcome assessor, controlled trial (PROBE) design 
was used to assess trained family-led caregiver-delivered, home-based stroke rehabilitation 
compared to routine care. The study site for the pilot phase was the Stroke Unit of the 
Department of Neurology at Christian Medical College and Hospital in Ludhiana, India. 
Patients were included if they were aged ≥18 years with residual disability (defined as 
requiring help from another person for everyday activities), within one month of a clinically 
definite acute stroke of any pathological type except subarachnoid hemorrhage. Patients were 
excluded if they were assessed as being at a high probability of death within the next 6 
months, or were unable to identify a suitable family-nominated caregiver for training and 
subsequent delivery of care. All patients (or their authorized representative) provided consent 
and the study was approved by the ethics committee of Christian Medical College and 
Hospital, Ludhiana.  
Procedures 
Eligible patients were randomized within 7 days of hospital admission, using random 
allocation software (RALOC) version 1.0.0 (developed by M. Saghaei, Isfahan University of 
Medical Sciences, Iran). This list was generated by a biostatistician and conveyed by 
telephone to the trial physiotherapist. 
Patients allocated to the intervention arm had their family nominated caregiver trained by a 
trial physiotherapist, using a structured assessment (cognition, language, function and 
mobility) and recommended rehabilitation package. Components of the evidence based 
intervention package included: (i) information on stroke recovery trajectory, risk, 
identification and management of low mood and the importance of repeated practice of task 
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specific activities, (ii) joint goal setting with patient, nominated family caregiver and therapist 
(reviewed with the therapist as patient progresses and new goals set), (iii) positioning, 
transfers and mobility, (iv) task orientated training (particularly walking, upper-limb and self-
care tasks) and (v) discharge planning. The local team developed a culturally appropriate, 
simple, pictorial ‘manual’ covering key exercises relevant to activities of daily living. In 
addition to the manual, training exercises were also chosen from the website 
http://www.physiotherapyexercises.com or as determined best for the patient by the therapist, 
all adhering to the intervention package. 
The trial therapist was trained in delivering the intervention package to the patient caregiver. 
The caregiver training was to commence in the hospital for approximately 60 minutes per day 
for about 3 days (with the intention of accelerating the patient’s hospital discharge when it 
was safe to do so). Afterwards, the caregiver would continue the intervention when the patient 
was discharged home. The trial therapist was able to be contacted through telephone for 
support and guidance over the next 3 months.  
Patients randomized to receive routine care were free to access rehabilitation services 
provided on an in-or-out- patient basis after discharge from hospital but caregivers were not 
provided with trial-specific training. 
The primary feasibility measures were recruitment, acceptance of intervention and 
assessments, and loss to follow-up. The primary clinical outcome of the trial was good 
functional recovery defined by scores 0-2 on the mRS (modified Rankin Scale)9  at 3 and 6 
months. 
Secondary clinical outcomes included a battery of planned measures to be used in the main 
phase of the trial: simple validated recovery and dependency questions,10 WHO Quality of 
Life (WHOQOL)- BREF,11,12 Nottingham Extended Activities of Daily Living (NEADL),13 
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Hospital Anxiety and Depression Scale (HADS),14Caregiver Burden Scale (CBS)15and Euro 
QoL (EQ-5D-3L)16, 17(all at 3 and 6 months) and direct medical costs associated with health 
care utilization. Reported here are the combined results from both treatment groups to 
illustrate the range of outcomes for the included patients. 
Follow-up assessment and documentation of outcomes were undertaken by face-to-face 
interview, either at home (for a small number of patients) or in a clinic at the hospital, at 3 
and 6 months. These assessments were done by a psychologist who was blinded to the 
treatment allocation. 
Statistical analysis 
The data by treatment allocation from the participants presented in this pilot study will 
contribute to the planned meta-analysis when data for the main trial is published and 
therefore primary and secondary outcomes divided by group and between-group differences 
are not presented here. Instead, data were analyzed descriptively [with frequencies, means, 
medians and interquartile ranges] using SPSS version 21.0 (Armonk, NY: IBM Corp 2013). 
Results 
A total of 379 patients were assessed for eligibility and 104 patients were recruited between 
December 2011 and September 2012. Fifty patients were allocated to the intervention group, 
and fifty four to the control group. Loss to follow-up at 6 months was 15 participants; 89 
patients (intervention group: 44; control group: 45) completed the trial (Figure 1). Other 
feasibility issues are shown in Figure 2.   
The baseline demographic details are shown in Table 1. The grouped primary and secondary 
outcome measures are shown in Table 2 and 3 respectively.  Out of the 90 patients followed 
up at 90 days, 26 (29%) patients had a good outcome (mRS 0-2) and 64 (71%) a poor 
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outcome (mRS 3-6). At the 6th month of follow-up (n=89), 35 (39%) had a good outcome and 
54 (61%) had a poor outcome. The median direct medical cost was USD 405 (interquartile 
range: USD 260- USD 882) and the highest charges were incurred for ‘hospital stay charges’, 
the median for which was USD 162 (Table 4).  
Discussion 
The pilot trial demonstrated excellent recruitment at the study site. In a span of 9 months, 104 
patients were recruited. The recruitment was achieved using just one full-time trial staff (in 
addition to the treating neurologist). 
Unlike in many drug trials where patients may often decline randomization due to fear of side 
effects, all of the medically stable patients from those screened for eligibility, agreed to be 
randomized.  
The intervention, being a simple one, is easily understood by the lay persons in India, 
including many who are uneducated and illiterate, and this probably spurred patient and 
caregiver interest which was sustained over time. The therapist was also likely to have 
established a good rapport with the patients’ families, which we hope facilitates tapping the  
unrealized human resources within the family for cost-effective stroke rehabilitation. 
We note that only 39% of the participants were independent (mRS: 0-2) at six months, 
confirming the poor long-term outcome of our selected trial population. These data, together 
with the other summary results (Tables 1-4) highlight the potential for improving post stroke 
rehabilitation in India using the family caregiver. 
But we also learnt some valuable lessons from the pilot study, as we prepared to recruit for 
the main study.  
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One main issue, as expected, was contamination between groups. The trial therapist also 
being the routine hospital physiotherapist for the unit naturally caused contamination. Also, 
the trial intervention manual was given to the intervention patient in the hospital that aroused 
interest from other patients, also leading to intervention contamination. For the main study, 
since there is more funding key changes to the logistics of running the trial included the 
decision to have dedicated trial staff for recruiting and delivering the intervention. This 
strategy was adopted to avoid therapists treating both control and experimental participants. 
Trial standard operating procedures were also developed to further reduce the risk of 
contamination e.g. the intervention to experimental participations will be provided in a 
separate area or behind curtains, the trial manual will only be provided at the first home visit 
by the trial therapist, the routine hospital physiotherapists will not participate in any trial 
procedures or training. 
Fifteen patients were lost to follow-up (which included two who refused follow-up); the 
majority was due to a wrong contact number, frequent changes in mobile phone numbers and 
changes in residential locations. For the main study, we sought to overcome this by gathering 
multiple phone numbers and addresses of patients and relatives and more funding allocation 
for the follow-up study staff to travel in search of trial subjects. 
The questionnaires, including the multiple complex tools used in the pilot study were overall 
found to be appropriate for our trial population. But we further refined and redesigned the 
questionnaires for the main study to tightly match the study protocol. They were translated to 
vernacular languages of each site, in addition to English, for easy participant understanding.  
For the multicenter roll-out of the main trial, we have developed a more detailed intervention 
manual capturing the important components of the intervention (assessment, goal setting, and 
training activities) with a greater emphasis on evidence-based functional task activities. The 
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main trial therapists would be trained by a team of experts in delivering the intervention 
package uniformly across sites. 
We would be gathering study logs for the main study to determine the fidelity of the 
intervention- assessing the quality and quantity of intervention delivered. We would also be 
using methods to determine the acceptability of the outcome measures to the participants. We 
would, in addition, assess levels of unblinding amongst the main study outcome assessors by 
evaluating their experience. 
The pilot study, thus, gave us the rich training ground to test a complex behavioral 
intervention which has never before been done in India- family-led stroke rehabilitation. In 
LMICs, ongoing face-to-face physiotherapy is rarely available except to an elite few. There 
are not many out-patient therapy departments in the remote parts of the country or in many 
public (government-run) hospitals, and most families cannot afford transporting the sick 
stroke patient to receive out-patient therapy, all of which cause high levels of disability in 
stroke patients. Traditional long-term rehabilitation costs often limit the chronic recovery 
phase of stroke and low-cost alternatives seem to be the need of the hour.  
The lessons learnt from the pilot trial have formed the platform for the design of the main 
trial (ATTEND), which commenced recruitment in 2014 in more than 10 centers across 
India.  
Our feasibility data also strengthened the funding application for the main study that was 
granted by the Australian National Health and Medical Research Council at the end of 2012.  
Conclusion 
The pilot study highlighted the logistical issues that need to be considered for conducting a 
larger trial. The pilot also showed that it was feasible to conduct a trial (ATTEND) using an 
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intervention of an empowered caregiver to give home-based rehabilitation after stroke in 
India, which if positive has the potential to have a major impact in the delivery of cost-
effective stroke rehabilitation across the world. Such a home-based program may be useful 
even in developed countries, by tapping the underutilized enthusiasm of a loved one in caring 
for a sick family member, especially in a condition like stroke, where a few months of 
continuous rehabilitation can potentially minimize morbidity. 
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Table 1: The baseline demographic details in both the groups (n=104) 
Variables Number (%)  
Age (Mean ± SD)* 60±13 years 
Gender  
Men 61 (59) 
Marital status  
Married 101 (98) 
Unmarried 2 (2) 
Caregiver  
Spouse 64 (63) 
Other relative 37 (37) 
Education  
Lower† 25 (24) 
Upper‡ 77 (76) 
Living situation  
Independent 101 (97) 
Annual income 
(INR)§ 
 
<14,999 56 (54) 
15,000- 29,999 35 (34) 
30,000- 1,00,000 13 (12) 
Family  
Joint 73 (70) 
Nuclear 31 (30) 
17 
 
*standard deviation, †less than primary school completed, ‡completed secondary school and beyond, §Indian 
rupees 
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Table 2: Primary outcome measure (modified Rankin Scale) 
 
 
 
 
 
 
 
*modified Rankin Scale,†mRS: 0-2, ‡mRS: 3-6 
 
 
 
 
 
 
 
 
 
 
Variables Number (%) 
 
mRS* at 3 months follow-up n=90 
Good outcome† 26 (29) 
Poor outcome‡ 64 (71) 
mRS* at 6 months follow-up n=89 
Good outcome† 35 (39) 
Poor outcome‡ 54 (61) 
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Table 3: Secondary outcomes (WHOQOL, ADL, HADS, CBS and EQ-5D)  
Variables Median (IQR)* 
At 3 months follow-up n=75 
WHO QOL†  
Physical domain 50 (38-63) 
Psychological domain 50 (38-56) 
Social domain 56 (50-75) 
Environment domain 56 (44-64) 
ADL‡ 15 (5-19) 
HADS§ Number (%) 
Anxiety 38 (51) 
Depression 25 (34) 
CBS scale‖  
Burden 35 (47) 
EQ-5D  
Mobility   
Problems 41 (55) 
Self-care  
Problems 45 (61) 
Normal Activities  
Problems 47 (63) 
Pain/Discomfort  
Problems 51 (69) 
Anxiety/Depression  
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Problems 51 (69) 
At 6 months follow-up n=69 
WHO QOL Median (IQR)* 
Physical domain 56 (50-69) 
Psychological domain 56 (50-69) 
Social domain 75 (56-81) 
Environment domain 63 (50-75) 
ADL 18 (16-21) 
HADS Number (%) 
Anxiety 27 (40) 
Depression 19 (28) 
CBS scale  
Burden 34 (50) 
EQ-5D  
Mobility   
Problems 31 (46) 
Self-care  
Problems 31 (46) 
Normal Activities  
Problems 31 (46) 
Pain/Discomfort  
Problems 41 (60) 
Anxiety/Depression  
Problems 42 (62) 
*interquartile range, †WHO Quality of Life, ‡Nottingham extended activities of daily living, §Hospital Anxiety 
and Depression Scale, ‖Caregiver Burden Scale 
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Table 4: Direct medical cost at the time of admission (n=104) 
 
Variables Median (IQR)* 
 
 INR† USD 
Total Direct Medical Cost 24312 (15618- 52889) 405 (260-882) 
Admission charges 638 (616-694) 11 (10-12) 
Hospital stay charges 9700 (5755- 14590) 162 (96-243) 
Rehabilitation‡ Charges 980 (540-1755) 16 (9-29) 
Laboratory Charges 5750 (3910-6730) 96 (65-112) 
Imaging Charges 6600 (3230-8545) 110 (54-142) 
Drug Charges 6089 (2670-18976) 101 (45-316) 
*interquartile range, †Indian rupees, ‡included physiotherapy and occupational therapy 
 
